Center for Scientific Review; Notice of Closed Meetings, 9369-9370 [2022-03541]
Download as PDF
<![CDATA[
9369
Federal Register / Vol. 87, No. 34 / Friday, February 18, 2022 / Notices
• Note that additional grant programs
may be added pending Fiscal Year 2022
and future Fiscal Year appropriations.
Additionally, all RCORP grant award
recipients are supported by eight
cooperative agreements: RCORPTechnical Assistance, which provides
extensive technical assistance to award
recipients; RCORP-Evaluation, which
evaluates the impact of the RCORP
initiative on rural communities; three
RCORP-Behavioral Health Care
Workforce Centers, which provide
workforce training and education
initiatives in the region served by the
Northern Border Regional Commission;
and three RCORP-Centers of Excellence,
which disseminate best practices related
to the treatment for and prevention of
substance use disorders within rural
communities.
A 60-day notice published in the
Federal Register, 86 FR 69655
(December 8, 2021). There were no
public comments.
Need and Proposed Use of the
Information: Due to the growth in the
number of grant programs included in
the RCORP initiative, as well as
emerging SUD and other behavioral
health trends in rural communities,
HRSA is submitting a revised package
that includes changes to existing RCORP
performance measures as well as new
performance measures that better
demonstrate the impact of the initiative
on rural communities and reduce
burden on the grant recipients.
For this program, performance
measures were developed to provide
data on each RCORP initiative and to
enable HRSA to provide aggregate
program data required by Congress
under the Government Performance and
Results Act of 1993. These measures
cover the principal topic areas of
interest to the Federal Office of Rural
Health Policy, including: (a) Provision
of, and referral to, rural behavioral
health care services, including SUD
prevention, treatment and recovery
support services; (b) behavioral health
care, including SUD prevention,
treatment, and recovery, process and
outcomes; (c) education of health care
providers and community members; (d)
emerging trends in rural behavioral
health care needs and areas of concern;
and (e) consortium strength and
sustainability. All measures will speak
to the Federal Office of Rural Health
Policy’s progress toward meeting the
goals set.
Likely Respondents: The respondents
will be the grant award recipients of the
RCORP initiatives.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
The below burden estimate is
significantly lower than the original
package submitted in 2019 (2,750 total
burden hours). This is likely due to the
fact that (1) many of the grant recipients
HRSA consulted to obtain the burden
estimate for this ICR revision have been
collecting and reporting RCORP
performance measures since March
2020 and have a better understanding of
the burden required; (2) HRSA
eliminated and/or streamlined some of
the more burdensome prevalence and
workforce measures; and (3) grant
recipients of the RCORPPsychostimulant program will only
report on an annual (vs. biannual) basis.
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Number of
respondents
Form name
Rural Communities Opioid Response Program-Implementation/Neonatal Abstinence Syndrome/MAT Expansion ..
Rural Communities Opioid Response ProgramPsychostimulant Support ..................................................
jspears on DSK121TN23PROD with NOTICES1
Total ..............................................................................
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022–03499 Filed 2–17–22; 8:45 am]
BILLING CODE 4165–15–P
VerDate Sep<11>2014
18:54 Feb 17, 2022
Jkt 256001
Number of
responses per
respondent
(annually)
580
1.24
719.20
15
1
15
1.30
19.50
305
........................
595
........................
738.70
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
Fmt 4703
Total burden
hours
2
National Institutes of Health
Frm 00063
Average
burden per
response
(in hours)
290
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PO 00000
Total
responses
Sfmt 4703
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–TR–
20–001: Ethical Issues in Translational
Science Research (R01 Clinical Trial
Optional).
Date: March 15, 2022.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sara Louise Hargrave,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
E:\FR\FM\18FEN1.SGM
18FEN1
jspears on DSK121TN23PROD with NOTICES1
9370
Federal Register / Vol. 87, No. 34 / Friday, February 18, 2022 / Notices
Health, 6701 Rockledge Drive, Room 3170,
Bethesda, MD 20892, (301) 443–7193,
hargravesl@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–21–
155: R15 Research Enhancement Award
(AREA & REAP) Applications.
Date: March 16, 2022.
Time: 1:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Rass M. Shayiq, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2182,
MSC 7818, Bethesda, MD 20892, (301) 435–
2359, shayiqr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
conflict: Mechanisms in Cell and
Developmental Biology.
Date: March 16, 2022.
Time: 3:00 p.m. to 7:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jonathan Arias, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5170,
MSC 7840, Bethesda, MD 20892, 301–435–
2406, ariasj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Infectious Diseases,
Immunology and HIV/AIDS Biological.
Date: March 22–23, 2022.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sharon Isern, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 810J,
Bethesda, MD 20892, (301) 594–8197,
iserns2@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–NS–
22–002: Advancing Equity in Pain
Management.
Date: March 22, 2022.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Randolph Christopher
Capps, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 1009J, Bethesda, MD 20892, (301) 435–
1042, cappsrac@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Surgical Sciences, Biomedical
Imaging and Bioengineering.
Date: March 22, 2022.
VerDate Sep<11>2014
18:54 Feb 17, 2022
Jkt 256001
Time: 12:00 p.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Weihua Luo, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5114,
MSC 7854, Bethesda, MD 20892, 301–435–
1170, luow@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Medical Imaging Investigations.
Date: March 25, 2022.
Time: 9:00 a.m. to 9:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Guo Feng Xu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5122,
MSC 7854, Bethesda, MD 20892, (301) 237–
9870, xuguofen@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Interdisciplinary Molecular
Sciences and Training Neuroimaging
Technologies.
Date: March 25, 2022.
Time: 9:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mufeng Li, Ph.D.,
Scientific Review Officer, The Center for
Scientific Review, The National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, 301–435–5653, limuf@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–OD–
21–004: Maximizing the Scientific Value of
Existing Biospecimen Collections (R21).
Date: March 25, 2022.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maria Dolores Arjona
Mayor, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institute of Health, 6701 Rockledge Drive,
Room 806D, Bethesda, MD 20892, (301) 86–
5309, arjonamayorm2@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA Panel:
Exploratory/Developmental Research,
Clinical Trials Readiness, Phased Innovation,
and Data Science in Down Syndrome for the
INCLUDE Project.
Date: March 25, 2022.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
PO 00000
Frm 00064
Fmt 4703
Sfmt 9990
Contact Person: Natalia Komissarova,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5207,
MSC 7846, Bethesda, MD 20892, (301) 435–
1206, komissar@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts: Topics in Environmental
Toxicology.
Date: March 25, 2022.
Time: 1:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aiping Zhao, MD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2188,
MSC 7818, Bethesda, MD 20892–7818, (301)
435–0682, zhaoa2@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics in physiological and
toxicological mechanisms.
Date: March 25, 2022.
Time: 1:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jianxin Hu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2156,
MSC 7818, Bethesda, MD 20892, (301) 827–
4417, jianxinh@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–RM–
21–014: Limited Competition: Continued
Development of the Gabriella Miller Kids
First Pediatric Data Resource Center (U2C).
Date: March 25, 2022.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Joonil Seog, SCD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, 301–402–9791, joonil.seog@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 14, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–03541 Filed 2–17–22; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\18FEN1.SGM
18FEN1
]]>Agencies
[Federal Register Volume 87, Number 34 (Friday, February 18, 2022)]
[Notices]
[Pages 9369-9370]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-03541]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA-TR-20-001: Ethical Issues in Translational Science
Research (R01 Clinical Trial Optional).
Date: March 15, 2022.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sara Louise Hargrave, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
[[Page 9370]]
Health, 6701 Rockledge Drive, Room 3170, Bethesda, MD 20892, (301)
443-7193, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-21-155: R15 Research Enhancement Award (AREA & REAP)
Applications.
Date: March 16, 2022.
Time: 1:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Rass M. Shayiq, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2182, MSC 7818, Bethesda, MD
20892, (301) 435-2359, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member conflict: Mechanisms in Cell and Developmental
Biology.
Date: March 16, 2022.
Time: 3:00 p.m. to 7:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jonathan Arias, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5170, MSC 7840, Bethesda, MD
20892, 301-435-2406, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Infectious Diseases, Immunology and HIV/AIDS
Biological.
Date: March 22-23, 2022.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sharon Isern, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 810J, Bethesda, MD 20892, (301) 594-8197,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA-NS-22-002: Advancing Equity in Pain Management.
Date: March 22, 2022.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Randolph Christopher Capps, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1009J, Bethesda, MD 20892, (301)
435-1042, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Surgical Sciences, Biomedical Imaging and
Bioengineering.
Date: March 22, 2022.
Time: 12:00 p.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Weihua Luo, MD, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5114, MSC 7854, Bethesda, MD
20892, 301-435-1170, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Medical Imaging Investigations.
Date: March 25, 2022.
Time: 9:00 a.m. to 9:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Guo Feng Xu, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5122, MSC 7854, Bethesda, MD 20892, (301) 237-
9870, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Interdisciplinary Molecular Sciences and
Training Neuroimaging Technologies.
Date: March 25, 2022.
Time: 9:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mufeng Li, Ph.D., Scientific Review Officer, The
Center for Scientific Review, The National Institutes of Health,
6701 Rockledge Drive, Bethesda, MD 20892, 301-435-5653,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA-OD-21-004: Maximizing the Scientific Value of Existing
Biospecimen Collections (R21).
Date: March 25, 2022.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maria Dolores Arjona Mayor, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institute of
Health, 6701 Rockledge Drive, Room 806D, Bethesda, MD 20892, (301)
86-5309, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA Panel: Exploratory/Developmental Research, Clinical
Trials Readiness, Phased Innovation, and Data Science in Down
Syndrome for the INCLUDE Project.
Date: March 25, 2022.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Natalia Komissarova, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5207, MSC 7846, Bethesda, MD
20892, (301) 435-1206, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflicts: Topics in Environmental Toxicology.
Date: March 25, 2022.
Time: 1:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aiping Zhao, MD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 2188, MSC 7818, Bethesda, MD 20892-7818, (301)
435-0682, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Topics in physiological and toxicological
mechanisms.
Date: March 25, 2022.
Time: 1:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jianxin Hu, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 2156, MSC 7818, Bethesda, MD 20892, (301) 827-
4417, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA-RM-21-014: Limited Competition: Continued Development of
the Gabriella Miller Kids First Pediatric Data Resource Center
(U2C).
Date: March 25, 2022.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Joonil Seog, SCD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, 301-402-9791,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: February 14, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-03541 Filed 2-17-22; 8:45 am]
BILLING CODE 4140-01-P
